Paper7628985
Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.
van Etten EW and 4 others. J Antimicrob Chemother, 1995. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans. Papers, record 7628985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7628985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Candidiasis | Major topic |
| Leukopenia | Major topic |
| Animals | |
| Chromatography, High Pressure Liquid | |
| Cyclophosphamide | |
| Drug Carriers | |
| Female | |
| Gallium Radioisotopes | |
| Isotope Labeling | |
| Liposomes | |
| Mice | |
| Mice, Inbred BALB C | |
| Tissue Distribution |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36411251 | Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitis. | J Antimicrob Chemother | 2022 | https://conductscience.org/library/papers/36411251 | PubMed |
| 35970966 | Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity. | AAPS PharmSciTech | 2022 | https://conductscience.org/library/papers/35970966 | PubMed |
| 34634395 | Nanomedicine to fight infectious disease. | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/34634395 | PubMed |
| 34633846 | DectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/34633846 | PubMed |
| 33523419 | Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections. | Infect Dis Ther | 2021 | https://conductscience.org/library/papers/33523419 | PubMed |
| 31222254 | Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/31222254 | PubMed |
| 30962332 | In Vitro and In Vivo Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30962332 | PubMed |
| 29263075 | Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29263075 | PubMed |
| 28928478 | Biomimetically engineered Amphotericin B nano-aggregates circumvent toxicity constraints and treat systemic fungal infection in experimental animals. | Sci Rep | 2017 | https://conductscience.org/library/papers/28928478 | PubMed |
| 28630200 | Pharmacodynamics and Biodistribution of Single-Dose Liposomal Amphotericin B at Different Stages of Experimental Visceral Leishmaniasis. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28630200 | PubMed |
| 23793994 | Dual physiologically based pharmacokinetic model of liposomal and nonliposomal amphotericin B disposition. | Pharm Res | 2014 | https://conductscience.org/library/papers/23793994 | PubMed |
| 22131622 | Formulation and Evaluation of Long Circulating Liposomal Amphotericin B: A Scinti-kinetic Study using Tc in BALB/C Mice. | Indian J Pharm Sci | 2011 | https://conductscience.org/library/papers/22131622 | PubMed |
| 21151883 | A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model. | PLoS Negl Trop Dis | 2010 | https://conductscience.org/library/papers/21151883 | PubMed |
| 17722276 | Optimizing efficacy of amphotericin B through nanomodification. | Int J Nanomedicine | 2006 | https://conductscience.org/library/papers/17722276 | PubMed |
| 16641459 | Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16641459 | PubMed |
| 16436726 | Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16436726 | PubMed |
| 16304147 | Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16304147 | PubMed |
| 12019089 | Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12019089 | PubMed |
| 11709329 | Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11709329 | PubMed |
| 10681316 | A sensitive amphotericin B immunoassay for pharmacokinetic and distribution studies. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10681316 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7628985
GET https://conductscience.org/api/papers/v1/7628985/cited_by?page=2